Literature DB >> 8869870

Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy.

B M Pluim1, J C Chin, A De Roos, J Doornbos, H M Siebelink, A Van der Laarse, H W Vliegen, R M Lamerichs, A V Bruschke, E E Van der Wall.   

Abstract

We investigated whether left ventricular hypertrophy in elite cyclists is associated with functional changes or abnormal energy metabolism. Left ventricular hypertrophy is a powerful risk factor for sudden cardiac death with different prognostic significance among the various geometric forms. Cyclists may have a combination of mixed eccentric and concentric hypertrophy. Magnetic resonance imaging was used to define left ventricular mass, geometry and function. Thirteen highly trained male cyclists and 12 healthy controls were investigated. Proton-decoupled phosphorus-31 cardiac spectroscopy was performed to assess parameters of myocardial high-energy phosphate metabolism. Left ventricular mass and end-diastolic volumes normalized for body surface area were significantly higher in cyclists (124.1 +/- 9.4 g.m-2 and 106.2 +/- 11.4 ml.m-2, respectively) than in controls (85.9 +/- 9.3 g.m-2 and 79.1 +/- 11.6 ml.m-2, respectively), (both P < 0.0001). The left ventricular mass to end-diastolic volume ratio, as a parameter of left ventricular geometry, was not significantly increased in cyclists compared to controls. Resting left ventricular ejection fraction, cardiac index, and systolic wall stress in cyclists did not differ significantly from those of controls. The phosphocreatine to adenosine triphosphate ratio was not significantly different between cyclists and controls (2.2 +/- 0.34 vs 2.2 +/- 0.17, ns). Cyclists show prominent left ventricular hypertrophy with normal geometry. The finding that the hypertrophic hearts of the cyclists had normal left ventricular function and a normal phosphocreatine to adenosine triphosphate ratio suggests that sport-induced left ventricular hypertrophy is a physiological adaptation rather than a pathophysiological response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869870     DOI: 10.1093/oxfordjournals.eurheartj.a015046

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

1.  Hypertension control is needed in elderly marathon runners!

Authors:  Arnoud van der Laarse; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

Review 2.  Human cardiac MR spectroscopy--clinical methods and applications.

Authors:  M Beer; D Hahn; S Neubauer
Journal:  MAGMA       Date:  1998-09       Impact factor: 2.310

3.  Echocardiography in Takotsubo cardiomyopathy; a useful approach?

Authors:  E E van der Wall; E R Holman; A J Scholte; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-06       Impact factor: 2.357

4.  Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?

Authors:  E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

5.  Left ventricular mass assessment by CMR; how to define the optimal index.

Authors:  E E van der Wall; H M Siebelink; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-06       Impact factor: 2.357

6.  Positron emission tomography; viable tool in patients pre-CABG?

Authors:  E E van der Wall; H M Siebelink; A J Scholte; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-04-01       Impact factor: 2.357

7.  Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual?

Authors:  E E van der Wall; J J Bax; J H Reiber
Journal:  Int J Cardiovasc Imaging       Date:  2010-05-08       Impact factor: 2.357

8.  Assessment of left ventricular function: visual or quantitative?

Authors:  E E van der Wall; J H C Reiber
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-28       Impact factor: 2.357

9.  Cardiac magnetic resonance imaging in primary PCI: additional value?

Authors:  E E van der Wall; J J Bax; J W Jukema; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-26       Impact factor: 2.357

10.  Cardiovascular dynamics in ischemic cardiomyopathy during exercise.

Authors:  E E van der Wall; J J Bax; C A Swenne; P Steendijk; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.